Old Web
English
Sign In
Acemap
>
authorDetail
>
Neika Vendetti
Neika Vendetti
Merck & Co.
Internal medicine
Medicine
Imipenem
Relebactam
Colistin
3
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Design of a Phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men.
2021
Contemporary Clinical Trials
Anna R. Giuliano
Timothy J. Wilkin
Oliver Bautista
Kyeongmi Cheon
Laurie Connor
Sheri Dubey
Alain Luxembourg
Sonali Rawat
Anita Shaw
Christine Velicer
Neika Vendetti
Yingmei Tu
Show All
Source
Cite
Save
Citations (0)
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
2020
Open Forum Infectious Diseases
Michelle L. Brown
Johann Motsch
Keith S Kaye
Thomas M. File
Helen W. Boucher
Neika Vendetti
Angela Aggrey
Hee-Koung Joeng
Robert W. Tipping
Jiejun Du
Daryl D. Depestel
Joan R. Butterton
Amanda Paschke
Show All
Source
Cite
Save
Citations (7)
1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
2018
Open Forum Infectious Diseases
Michelle Brown
Johann Motsch
Keith S Kaye
Thomas M. File
Helen W. Boucher
Neika Vendetti
Angela Aggrey
Hee-Koung Joeng
Robert W. Tipping
Jiejun Du
Daryl D. Depestel
Joan R. Butterton
Nicholas A. Kartsonis
Amanda Paschke
Show All
Source
Cite
Save
Citations (0)
1